2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents

James L. Januzzi, Jr., MD, FACC Chair, ACC Task Force on Expert Consensus Decision Pathways1 Abstract Tobacco use, especially cigarette smoking, is a major risk factor for cardiovascular morbidity and mortality and is the leading preventable cause of death worldwide. Patients who use any tobacco pro...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the American College of Cardiology 2018-12, Vol.72 (25), p.3332-3365
Main Authors:	Barua, Rajat S, Rigotti, Nancy A, Benowitz, Neal L, Cummings, K Michael, Jazayeri, Mohammad-Ali, Morris, Pamela B, Ratchford, Elizabeth V, Sarna, Linda, Stecker, Eric C, Wiggins, Barbara S
Format:	Article
Language:	eng
Subjects:	Advisory Committees - standards Algorithms Ambulatory care Aorta Appendix Cancer Cardiology Cardiology - methods Cardiology - standards Cardiovascular disease Cardiovascular diseases Cerebral infarction Cigarette smoke Cigarette smoking Clinical decision making Clinical Decision-Making - methods Consensus Coronary artery disease Decision making Disease prevention Epidemiology Expert Testimony - methods Expert Testimony - standards Health risks Heart Heart diseases Hospitals Humans Low level Morbidity Myocardial infarction Nicotine Patients Preventive medicine Research Report - standards Risk analysis Risk factors Smoke Smoking Smoking cessation Task forces Tobacco Tobacco smoking Tobacco Use Cessation - methods United States - epidemiology Vascular diseases
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	James L. Januzzi, Jr., MD, FACC Chair, ACC Task Force on Expert Consensus Decision Pathways1 Abstract Tobacco use, especially cigarette smoking, is a major risk factor for cardiovascular morbidity and mortality and is the leading preventable cause of death worldwide. Patients who use any tobacco product should receive clear advice to stop tobacco use and be offered a brief intervention that includes prescriptions for proven pharmacological smoking cessation aids and proactive connection to evidence-based behavioral support based in the healthcare system and/or the community. Clinically, tobacco smoking increases the risk of coronary heart disease (CHD) (including myocardial infarction [MI] and sudden death), cerebrovascular disease (stroke), peripheral artery disease, and abdominal aortic aneurysm (10,12,13). Experimental, epidemiological, and clinical studies demonstrate a nonlinear dose effect of cigarette smoke exposure on CV function and CVD such that a low level of cigarette use is associated with a disproportionately large excess in CV risk (10,11,20–22).
ISSN:	0735-1097 1558-3597